Organigram Global Inc [OGI] stock is trading at $1.16, up 1.75%. An important factor to consider is whether the stock is rising or falling in short-term value. The OGI shares have gain 7.41% over the last week, with a monthly amount glided 14.85%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Alliance Global Partners upgraded its rating to Buy on April 15, 2024. On January 13, 2023, upgrade upgraded it’s rating to Buy. Canaccord Genuity upgraded its rating to a Speculative Buy. CIBC upgraded its rating to a Neutral. CIBC downgraded its rating to Sector Underperform for this stock on April 14, 2021. In a note dated April 08, 2021, BMO Capital Markets upgraded an Market Perform rating on this stock.
Organigram Global Inc [OGI] stock has fluctuated between $0.85 and $2.17 over the past year. Organigram Global Inc [NASDAQ: OGI] shares were valued at $1.16 at the most recent close of the market.
Analyzing the OGI fundamentals
Organigram Global Inc [NASDAQ:OGI] reported sales of 121.24M for the trailing twelve months, which represents a growth of 14.16%. Gross Profit Margin for this corporation currently stands at 0.27% with Operating Profit Margin at -0.24%, Pretax Profit Margin comes in at -0.32%, and Net Profit Margin reading is -0.32%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.18 and Total Capital is -0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1003 points at the first support level, and at 1.0405 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.2099, and for the 2nd resistance point, it is at 1.2597.
Ratios To Look Out For
For context, Organigram Global Inc’s Current Ratio is 3.36. On the other hand, the Quick Ratio is 1.85, and the Cash Ratio is 0.64. Considering the valuation of this stock, the price to sales ratio is 1.21, the price to book ratio is 0.65.
